Home/🇺🇸 United States/Cross Country Healthcare to be acquired by Knox Lane at $13.25/share

🇺🇸 United States

Cross Country Healthcare to be acquired by Knox Lane at $13.25/share

·Published May 12, 2026, 5:30 PM UTC0🤖 AI-Synthesized

TLDR

●Knox Lane acquiring Cross Country Healthcare at $13.25/share in all-cash take-private deal
●Analysts recommend selling stock, signaling limited upside beyond acquisition offer price
●Deal requires regulatory approvals and shareholder vote before closing completion

AI-Synthesized news from multiple sources

This article was synthesized by AI from the source articles listed below, reviewed by a second-pass AI quality reviewer, and published by the market.news editorial system. How we do this · Editorial standards · Report an error

The Quick Take

Knox Lane, a private equity firm, is acquiring Cross Country Healthcare (CCRN) at $13.25/share in an all-cash deal
The acquisition price of $13.25/share represents the cash-out value for CCRN shareholders in this take-private transaction
Analyst commentary from Seeking Alpha suggests investors should sell into the deal, implying limited upside beyond the offer price
Next step: deal closing process, regulatory approvals, and shareholder vote expected before transaction finalizes
Global healthcare staffing M&A activity signals ongoing consolidation in the sector, relevant to Asia-Pacific healthcare workforce firms

Synthesized from 1 source — full coverage, sentiment breakdown, and forward signals below.

AI Indicators

Market Intelligence Panel

Sentiment

Neutral

🟢 0⚪ 1🔴 0

Coverage

live

source covering this story

T1: 1T2: 0T3: 0

Live Price

FOREXCOM:SPXUSD

📊 Key Numbers

Guidance$13.25

🌍 India / Asia Angle

The CCRN take-private highlights private equity appetite for healthcare staffing amid global nursing shortages; Indian healthcare staffing firms like TeamLease Health and staffing-adjacent players may attract similar PE interest as Asia faces comparable workforce demand dynamics.

🌊 Ripple Effects

▸Healthcare staffing sector (US) — upward pressure as M&A activity signals sector undervaluation and PE interest
▸Private equity (healthcare focus) — bullish signal for deal flow in staffing/temp workforce space amid labor market normalization
▸CCRN equity — price expected to converge tightly to $13.25 offer price, removing meaningful trading upside or downside

🔭 What to Watch Next

PRO

▸Regulatory clearance timeline — monitor HSR antitrust filing and expected review period for deal closing date
▸CCRN shareholder vote — watch for proxy statement filing and vote date to confirm deal approval likelihood
▸Comparable healthcare staffing names (AMN Healthcare, TrueBlue) — monitor for re-rating or copycat M&A speculation

Market news synthesis. Not financial advice. Sources cited above.

Timeline

How the Story Spread

1 publishers · 1 time windows

May 8, 11:00 AMNow · 4d ago

+1 source · total: 1

seekingalpha.com

All Sources

1 publisher covering this story

● Tier 1: 1

AI synthesis of every source listed below. Tier 1 = wire services (AP, Reuters via wire, Bloomberg, official central banks). Tier 2 = major financial publishers. Tier 3 = niche / specialist outlets. Click any card to read the original article.

● Tier 1 — Wire & primary sources

seekingalpha.comTIER 1seekingalpha.com4d ago

Cross Country Healthcare: Time To Cash Out After A New Merger (NASDAQ:CCRN)

Cross Country Healthcare is being acquired by P/E firm Knox Lane for $13.25 per share in an all-cash transaction. Read more on CCRN stock here.

Read on seekingalpha.com

Get the Daily Briefing

Pre-market analysis every morning at 6am ET. Free.

Was this article useful?

Anonymous · helps us tune the editorial system

Banking & Financial Services Desk

Sarah Williams

Sarah covers global banking — earnings, regulatory capital, M&A, and the systemic risk picture across US, UK and Asian banks. Former buy-side credit research before joining the desk.

View full profile →

More 🇺🇸 United States Stories